Pachter on PSVR: it is ‘highly likely to be’ $400 USD

    With the Oculus Rift pre-orders launched and that divisive price tag of $599 USD still being discussed by many in the industry, the focus is naturally going to move onto the other major headset manufacturers. Neither HTC/Valve or Sony Computer Entertainment (SCE) have yet to reveal an official price, although HTC Vive is expected to reveal this first as pre-orders were announced to be starting in February. For SCE’s PlayStation VR on the other hand nothing is expected just yet, possibly why well-known industry analyst from Wedbush Securities, Michael Pachter has been giving his opinions on the subject recently.    

    Via the newest episode of his Pachter Factor series the analyst said: “I think Morpheus (PlayStation VR) is highly likely to be 400 bucks. It’s gonna be hard… — if you actually look at the headset, there’s a lot there. So, I think it’s gonna be hard to price it below 300; It’s possible… if they believe they’re gonna make enough of them.

    “A lot of people don’t have a really high-end PC laying around, so I think the PlayStation 4 crowd has a huge advantage. Sony’s got an install base, as of November, of thirty million of them. So, I can see Sony planning to sell ten million Morpheus units. I doubt that they will sell those in the first year, because there probably won’t be a lot of content, but I can see them planning to sell 10 million over time,” reports

    The $400 USD price point is nothing new, after looking at previous statements from SCE saying that the PlayStation VR launch would be similar to a new console launch, hence around the $400 USD area. As the PlayStation VR is due to arrive in the first half of 2016 there’s still a few more months left to debate what the actual price will be before its officially unveiled.

    VRFocus will continue to bring you any new information on the PlayStation VR headset as SCE releases further details.


    The post Pachter on PSVR: it is ‘highly likely to be’ $400 USD appeared first on VRFocus.